Product Description: BMS-582949 hydrochloride is an orally active and highly selective p38α MAPK inhibitor, with an IC50 of 13 nM. BMS-582949 hydrochloride displays a significantly improved pharmacokinetic profile and is effective in inflammatory disease[1].
Applications: COVID-19-immunoregulation
Formula: C22H27ClN6O2
References: [1]Liu C, et al. Discovery of 4-(5-(cyclopropylcarbamoyl)-2-methylphenylamino)-5-methyl-N-propylpyrrolo[1,2-f][1,2,4]triazine-6-carboxamide (BMS-582949), a clinical p38α MAP kinase inhibitor for the treatment of inflammatory diseases. J Med Chem. 2010 Sep 23;53(18):6629-39.
CAS Number: 912806-16-7
Molecular Weight: 442.94
Compound Purity: 98.90
Research Area: Inflammation/Immunology
Solubility: DMSO : 25 mg/mL (ultrasonic)
Target: Autophagy;p38 MAPK